Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (31-40 of 352) with videos related to

Pageof 36
Sort By:
Antibiotics (Basel, Switzerland)|July 27, 2022
Protein Binding in Translational Antimicrobial Development-Focus on Interspecies DifferencesHifza Ahmed, Felix Bergmann, Markus Zeitlinger
Journal of Internal Medicine|August 4, 2025
Authors' reply: Systolic blood pressure targets below 120 mmHg are associated with reduced mortality: A meta-analysisFelix Bergmann, Markus Zeitlinger, Anselm Jorda
International Journal of Antimicrobial Agents|February 22, 2025
Interspecies differences in plasma protein binding of beta-lactam antibioticsHifza Ahmed, Christoph Dorn, Markus Zeitlinger
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Felix Bergmann, Anselm Jorda, Markus Zeitlinger
The AAPS Journal|December 16, 2005
Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)Markus Zeitlinger, Markus Müller, Christian Joukhadar
Frontiers in Pharmacology|March 6, 2023
Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality checkMarkus Zeitlinger, Glenn Tillotson, Roger Echols
Clinical Pharmacokinetics|July 24, 2015
Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase InhibitorsBeatrix Wulkersdorfer, Markus Zeitlinger, Monika Schmid
Infection|August 3, 2019
Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole bloodZoe Oesterreicher, Sabine Eberl, Markus Zeitlinger
European Journal of Drug Metabolism and Pharmacokinetics|April 13, 2026
Drug-Drug Interactions in Recently Approved Antibacterials: A Mini ReviewIsabella Baccari, Felix Bergmann, Markus Zeitlinger
Clinical Pharmacokinetics|December 17, 2008
Ketolides--the modern relatives of macrolides : the pharmacokinetic perspectiveMarkus Zeitlinger, Claudia Christina Wagner, Birgit Heinisch
Pageof 36

Showing results (31-40 of 352) with videos related to

Sort By:
Pageof 36
Antibiotics (Basel, Switzerland)|July 27, 2022
Protein Binding in Translational Antimicrobial Development-Focus on Interspecies DifferencesHifza Ahmed, Felix Bergmann, Markus Zeitlinger
Journal of Internal Medicine|August 4, 2025
Authors' reply: Systolic blood pressure targets below 120 mmHg are associated with reduced mortality: A meta-analysisFelix Bergmann, Markus Zeitlinger, Anselm Jorda
International Journal of Antimicrobial Agents|February 22, 2025
Interspecies differences in plasma protein binding of beta-lactam antibioticsHifza Ahmed, Christoph Dorn, Markus Zeitlinger
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Felix Bergmann, Anselm Jorda, Markus Zeitlinger
The AAPS Journal|December 16, 2005
Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)Markus Zeitlinger, Markus Müller, Christian Joukhadar
Frontiers in Pharmacology|March 6, 2023
Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality checkMarkus Zeitlinger, Glenn Tillotson, Roger Echols
Clinical Pharmacokinetics|July 24, 2015
Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase InhibitorsBeatrix Wulkersdorfer, Markus Zeitlinger, Monika Schmid
Infection|August 3, 2019
Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole bloodZoe Oesterreicher, Sabine Eberl, Markus Zeitlinger
European Journal of Drug Metabolism and Pharmacokinetics|April 13, 2026
Drug-Drug Interactions in Recently Approved Antibacterials: A Mini ReviewIsabella Baccari, Felix Bergmann, Markus Zeitlinger
Clinical Pharmacokinetics|December 17, 2008
Ketolides--the modern relatives of macrolides : the pharmacokinetic perspectiveMarkus Zeitlinger, Claudia Christina Wagner, Birgit Heinisch
Pageof 36